References
- Huang X, Borgstrm B, Stegmayr J, et al. The molecular basis for inhibition of stemlike cancer cells by salinomycin. ACS Cent Sci. 2018;4(6):760–767. doi:10.1021/acscentsci.8b0025729974072
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30. doi:10.3322/caac.2144229313949
- House CD, Jordan E, Hernandez L, et al. NFκB promotes ovarian tumorigenesis via classical pathways that support proliferative cancer cells and alternative pathways that support ALDH+ cancer stem-like cells. Cancer Res. 2017;77:6927–6940. doi:10.1158/0008-5472.CAN-17-036629074539
- Li J, Condello S, Thomes-Pepin J, et al. Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells. Cell Stem Cell. 2017;20:303–314.e5. doi:10.1016/j.stem.2016.11.00428041894
- Seo EJ, Kwon YW, Jang IH, et al. Autotaxin regulates maintenance of ovarian cancer stem cells through lysophosphatidic acid-mediated autocrine mechanism. Stem Cells. 2016;34:551–564. doi:10.1002/stem.227926800320
- Vaidyanathan S, Orr BG, Banaszak Holl MM. Role of cell membrane-vector interactions in successful gene delivery. Acc Chem Res. 2016;49(8):1486–1493. doi:10.1021/acs.accounts.6b0020027459207
- Guan X, Guo Z, Lin L, et al. Ultrasensitive pH triggered charge/size dual-rebound gene delivery system. Nano Lett. 2016;16(11):6823–6831. doi:10.1021/acs.nanolett.6b0253627643629
- Zhang H, Chen Z, Du M, et al. Enhanced gene transfection efficiency by low-dose 25 kDa polyethylenimine by the assistance of 1.8 kDa polyethylenimine. Drug Deliv. 2018;25(1):1740–1745. doi:10.1080/10717544.2018.151006530241446
- Luo X, Peng X, Hou J, et al. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer. Int J Nanomedicine. 2017;12:5331–5343. doi:10.2147/IJN28794626
- Lei Y, Wang J, Xie C, et al. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery. J Gene Med. 2013;15(8–9):291–305. doi:10.1002/jgm.272624038955
- Wang S, Zhou Z, Wang Z, et al. Gadolinium metallofullerene-based activatable contrast agent for tumor signal amplification and monitoring of drug release. Small. 2019;15(16):e1900691. doi:10.1002/smll.v15.1630913380
- Wang S, Wang Z, Yu G, et al. Tumor-specific drug release and reactive oxygen species generation for cancer chemo/chemodynamic combination therapy. Adv Sci (Weinh). 2019;6(5):1801986. doi:10.1002/advs.20180198630886808
- Eggen S, Fagerland SM, Mørch Ý, et al. Ultrasound-enhanced drug delivery in prostate cancer xenografts by nanoparticles stabilizing microbubbles. J Control Release. 2014;187:39–49. doi:10.1016/j.jconrel.2014.05.02024852099
- De Cock I, Lajoinie G, Versluis M, et al. Sonoprinting and the importance of microbubble loading for the ultrasound mediated cellular delivery of nanoparticles. Biomaterials. 2016;83:294–307. doi:10.1016/j.biomaterials.2016.01.02226796042
- Li Y, Lin Y, Liufu C, et al. Research of gene delivery mediated by ultrasound, microbubble and folate-modified chitosan nanoparticles. Curr Mol Med. 2018;18(6):383–391. doi:10.2174/156652401866618110912150930411684
- Jain A, Cheng K. The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis. J Control Release. 2017;245:27–40. doi:10.1016/j.jconrel.2016.11.01627865853
- Fan CH, Ting CY, Lin CY, et al. Noninvasive, targeted, and non-viral ultrasound-mediated GDNF-plasmid delivery for treatment of Parkinson’s disease. Sci Rep. 2016;6:19579. doi:10.1038/srep1957926786201
- Luo W, Wen G, Yang L, et al. Dual-targeted and pH-sensitive doxorubicin prodrug-microbubble complex with ultrasound for tumor treatment. Theranostics;2017 452–465. doi:10.7150/thno.1667728255342
- Ishiguro T, Sato A, Ohata H, et al. Establishment and characterization of an in vitro model of ovarian cancer stem-like cells with an enhanced proliferative capacity. Cancer Res. 2016;76:150–160. doi:10.1158/0008-5472.CAN-15-036126669863
- Park YT, Jeong JY, Lee MJ, et al. MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. J Ovarian Res. 2013;6:18. doi:10.1186/1757-2215-6-1823522567
- Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol. 2016;11:47–76. doi:10.1146/annurev-pathol-012615-04443827193450
- Medema JP. Cancer stem cells: the challenges ahead. Nat Cell Biol. 2013;15:338–344. doi:10.1038/ncb271723548926
- de Sousa E Melo F, Kurtova AV, Harnoss JM, et al. A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer. Nature. 2017;543:676–680. doi:10.1038/nature2171328358093
- Shimokawa M, Ohta Y, Nishikori S, et al. Visualization and targeting of LGR5(+) human colon cancer stem cells. Nature. 2017;545:187–192. doi:10.1038/nature2208128355176
- Yang C, Li B, Yu J, et al. Ultrasound microbubbles mediated miR-let-7b delivery into CD133+ ovarian cancer stem cells. Biosci Rep. 2018;38(5). doi:10.1042/BSR20180922
- Do HD, Couillaud BM, Doan BT, et al. Advances on non-invasive physically triggered nucleic acid delivery from nanocarriers. Adv Drug Deliv Rev. 2019;138:3–17. doi:10.1016/j.addr.2018.10.00630321618
- Liu Y, Xu CF, Iqbal S, et al. Responsive nanocarriers as an emerging platform for cascaded delivery of nucleic acids to cancer. Adv Drug Deliv Rev. 2017;115:98–114. doi:10.1016/j.addr.2017.03.00428396204
- Guan X, Guo Z, Wang T, et al. A pH-responsive detachable PEG shielding strategy for gene delivery system in cancer therapy. Biomacromolecules. 2017;18:1342–1349. doi:10.1021/acs.biomac.7b0008028272873
- Yoon YI, Kwon YS, Cho HS, et al. Ultrasound-mediated gene and drug delivery using a microbubble-liposome particle system. Theranostics. 2014;4:1133–1144. doi:10.7150/thno.994525250094
- Chang Kang H, Bae YH. Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide. Biomaterials. 2011;32:4914–4924. doi:10.1016/j.biomaterials.2011.03.04221489622
- Yang C, Li Y, Du M, Chen Z. Recent advances in ultrasound-triggered therapy. J Drug Target. 2018;27:1–18. doi:10.1080/1061186X.2018.145584129564914
- Luo MH, Yeh CK, Situ B, Yu JS, Li BC, Chen ZY. Microbubbles: a novel strategy for chemotherapy. Curr Pharm Des. 2017;23(23):3383–3390. doi:10.2174/138161282366617011309214828088911
- Yu J, Chen Z, Li Y, et al. Echogenic chitosan nanodroplets for spatiotemporally controlled gene delivery. J Biomed Nanotechnol. 2018;14(7):1287–1297. doi:10.1166/jbn.2018.257529944102
- Lee JL, Lo CW, Inserra C, et al. Ultrasound enhanced PEI-mediated gene delivery through increasing the intracellular calcium level and PKC-δ protein expression. Pharm Res. 2014;31:2354–2366. doi:10.1007/s11095-014-1332-424623478
- Yu J, Chen Z, Yan F. Advances in mechanism studies on ultrasonic gene delivery at cellular level. Prog Biophys Mol Biol. 2019;142:1–9. doi:10.1016/j.pbiomolbio.2018.07.01230031881
- Condello S, Morgan CA, Nagdas S, et al. β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids. Oncogene. 2015;34:2297–2308. doi:10.1038/onc.2014.17824954508
- Manta S, Renault G, Delalande A, et al. Cationic microbubbles and antibiotic-free miniplasmid for sustained ultrasound-mediated transgene expression in liver. J Control Release. 2017;262:170–181. doi:10.1016/j.jconrel.2017.07.01528710005